X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
mpdl3280a (113) 113
index medicus (95) 95
humans (87) 87
oncology (82) 82
immunotherapy (68) 68
cancer (54) 54
safety (52) 52
nivolumab (51) 51
pd-l1 (47) 47
anti-pd-l1 antibody (41) 41
female (39) 39
clinical activity (36) 36
antibody (33) 33
blockade (33) 33
melanoma (33) 33
tumors (33) 33
middle aged (32) 32
aged (31) 31
antibodies, monoclonal - therapeutic use (31) 31
immunohistochemistry (29) 29
male (29) 29
prognosis (27) 27
b7-h1 antigen - metabolism (26) 26
care and treatment (26) 26
chemotherapy (26) 26
metastasis (26) 26
antineoplastic agents - therapeutic use (24) 24
lymphocytes (24) 24
pd-1 (24) 24
pembrolizumab (24) 24
adult (23) 23
lung cancer (23) 23
docetaxel (22) 22
immunology (20) 20
mpdl3280a anti-pdl1 (20) 20
b7-h1 antigen - immunology (19) 19
ipilimumab (19) 19
ligands (19) 19
lung cancer, non-small cell (19) 19
survival (19) 19
expression (18) 18
cancer therapies (17) 17
carcinoma (17) 17
immunotherapy - methods (17) 17
aged, 80 and over (16) 16
article (16) 16
atezolizumab (16) 16
b7-h1 antigen - antagonists & inhibitors (16) 16
pd-l1 protein (16) 16
animals (15) 15
cell biology (15) 15
clinical trials (15) 15
lung neoplasms - drug therapy (15) 15
lung neoplasms - pathology (15) 15
programmed cell death 1 receptor - antagonists & inhibitors (15) 15
research (15) 15
antibodies (14) 14
apoptosis (14) 14
b7-h1 antigen - genetics (14) 14
carcinoma, non-small-cell lung - drug therapy (14) 14
medical prognosis (14) 14
patients (14) 14
biomarkers (13) 13
metastases (13) 13
open-label (13) 13
pd-l1 expression (13) 13
therapy (13) 13
treatment outcome (13) 13
analysis (12) 12
carcinoma, non-small-cell lung - pathology (12) 12
pathology (12) 12
pd-1 blockade (12) 12
responses (12) 12
antibody mpdl3280a (11) 11
biomarkers, tumor - metabolism (11) 11
disease-free survival (11) 11
lymphocytes t (11) 11
lymphocytes, tumor-infiltrating - immunology (11) 11
lymphocytes, tumor-infiltrating - metabolism (11) 11
monoclonal antibodies (11) 11
pd-1 protein (11) 11
research paper (11) 11
respiratory system (11) 11
cell death (10) 10
gene expression (10) 10
kaplan-meier estimate (10) 10
nsclc (10) 10
t-cells (10) 10
tumor-infiltrating lymphocytes (10) 10
antibodies, monoclonal, humanized - therapeutic use (9) 9
antigens (9) 9
b7-h1 (9) 9
b7-h1 antigen - biosynthesis (9) 9
biotechnology & applied microbiology (9) 9
breast cancer (9) 9
cell survival (9) 9
death-ligand 1 (9) 9
health aspects (9) 9
lung neoplasms - immunology (9) 9
lung neoplasms - therapy (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10030, pp. 1837 - 1846
Journal Article
Nature Communications, ISSN 2041-1723, 02/2017, Volume 8, Issue 1, p. 14572
Expression of PD-L1, the ligand for T-cell inhibitory receptor PD-1, is one key immunosuppressive mechanism by which cancer avoids eradication by the immune... 
LUNG-CANCER | IMMUNOTHERAPY | MULTIDISCIPLINARY SCIENCES | ANALYSIS TOOLS | ANTIBODY | MUTATIONS | BLOCKADE | MPDL3280A | ANTIGEN
Journal Article
Science, ISSN 0036-8075, 04/2015, Volume 348, Issue 6230, pp. 124 - 128
Immune checkpoint inhibitors, which unleash a patient's own T cells to kill tumors, are revolutionizing cancer treatment. To unravel the genomic determinants... 
RESPONSES | EPITOPE | ADVANCED MELANOMA | MULTIDISCIPLINARY SCIENCES | ANTIBODY | ANTIGENS | NIVOLUMAB | EXOME ANALYSIS REVEALS | T-CELLS | IPILIMUMAB | MPDL3280A | Genetic aspects | Gene mutations | Lung cancer, Non-small cell | Identification and classification | Lung cancer | Mutation | Mutations | Therapy | Effectiveness | Lungs | Palladium | Patients | Tumors | Cancer
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 389, Issue 10066, pp. 255 - 265
Journal Article
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 01/2017, Volume 12, Issue 1, pp. 110 - 120
Journal Article
Cancer Discovery, ISSN 2159-8274, 02/2017, Volume 7, Issue 2, pp. 188 - 201
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 908 - 918
Journal Article
British Journal of Cancer, ISSN 0007-0920, 12/2014, Volume 111, Issue 12, pp. 2214 - 2219
Background: Immune modulation in cancer refers to a range of treatments aimed at harnessing a patient's immune system to achieve tumour control, stabilisation,... 
anti-CTLA4 | anti-PD-L1 | nivolumab | tremelimumab | immunotherapy | BMS-936559 | anti-PD-1 | MPDL3280A | LYMPHOCYTE | SAFETY | ANTIBODY | PIDILIZUMAB | COMBINATION | METASTATIC MELANOMA | ONCOLOGY | BLOCKADE | IPILIMUMAB | Immunotherapy - methods | Neoplasms - therapy | Neoplasms - immunology | Humans | Index Medicus | Minireview
Journal Article